J&J tells jury it properly warned about Levaquin risks; Pfizer wins Viagra trademark fight;

@FiercePharma: $BMY earnings might have disappointed analysts--and Plavix is faltering--but newer meds grew--Bloomberg. Article | Follow @FiercePharma

> Johnson & Johnson ($JNJ) lawyers told Minneapolis jurors it properly warned about the risks of its antibiotic drug Levaquin, and so shouldn't be held liable for a patient's tendon injuries. Article

> Pfizer ($PFE) won a court battle over the Viagra trademark, preventing an energy drinks company from using the name Viaguara. Story

> Roche ($RHHBY) said it hasn't settled any claims that its Raptiva psoriasis drug triggered lethal infections, and a plaintiffs' lawyer who had announced a deal called his statement "wishful thinking." More

> Pfizer's ($PFE) aggressive bid to keep Lipitor sales might be protecting revenues at the expense of profits, said Paul Bisaro, CEO at Pfizer's authorized-generic partner Watson Pharmaceuticals ($WPI). Report

> The European Commission broadened use of the Merck Serono multiple sclerosis drug Rebif to patients with early signs of the disease. News

> Playing down misuse-of-funds allegations at the Global Fund to Fight AIDS, Bill Gates gave another $750 million to the organization and called on governments to pitch in more as well. Story

> Spectrum Pharmaceuticals ($SPPI) agreed to pay Bayer ($BAY) almost $25 million for the rights to market a lymphoma drug, Zevalin, outside the U.S. More

> European regulators are considering requiring API manufacturers to verify the sources of their raw materials as part of revised good manufacturing practice rules. Report

> Drug wholesaler AmerisourceBergen ($ABC) posted a slight rise in fourth-quarter profits to $162.1 million, falling short of analyst estimates. Article

> Grief could be characterized as a form of depression in the new Diagnostic and Statistical Manual of Mental Disorders. News

> A drug used in the U.S. to promote growth in pigs, but banned in the E.U. and other countries, has limited pork exports to key markets. Report

Biotech News

@FierceBiotech: A future threat to Provenge? Researchers target multiple tumors (prostate, lung, others) in new cancer vaccine study. Article | Follow @FierceBiotech

@JohnCFierce: Interesting note: Abingworth, a major Avila investor, also cashed out of Intellikine ($310M) in Dec. For VCs, M&A is key this year. | Follow @JohnCFierce

@MarkHFierce: Obama is pushing (again) for more funding for basic research. Is anybody going to listen this time? More | Follow @MarkHFierce

> Celgene snaps up Avila Therapeutics in $925M buyout. News

> Amgen scoops up Micromet tumor-fighting pipeline for $1.2B. Report

Vaccines News

> Common chemicals threaten childhood vaccines. Story

> Researchers target multiple tumors in new cancer vaccine study. More

> Nanoparticles hijack immune response. Article

> Late-stage Galena vax offers hope for breast cancer patients. Story

Pharma Manufacturing News

> Owner arrested in Pakistani drug deaths cites Big Pharma conspiracy. Article

> Abbott includes manufacturing in 700 job cuts. News

> Warnings analysis spotlights analytics weakness. Story

> Merck 'program of projects' earns facility award. More

And Finally... A Wisconsin scientist said his team's souped-up version of bird flu wasn't as lethal as the Dutch team's. Report

Suggested Articles

Gilead Sciences has found a new chief financial officer in an appointment that has mergers and acquisitions written all over it.

Pfizer's role as the hero in ramping up production of a chemo drug badly needed by pediatric oncologists is a turnabout for the drugmaker.

Johnson & Johnson is dealing with $2 billion in patent losses in 2019, but has 10 drugs growing at double-digit percentages, executives said Tuesday.